Intrinsic value of Tarsus Pharmaceuticals, Inc. (TARS)
Live fair value data for Tarsus Pharmaceuticals, Inc. (TARS) is currently unavailable. Please check again shortly.
Current Price: $114.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Tarsus Pharmaceuticals, Inc. (TARS) undervalued or overvalued?
Based on the current model output, Tarsus Pharmaceuticals, Inc. appears to be undervalued with a upside of 42.00%.
Fair value vs market price — Tarsus Pharmaceuticals, Inc. (TARS)
Unlock premium access to view the live fair value comparison against current market price for TARS.
Frequently Asked Questions - TARS
How is TARS intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for TARS.
Is TARS undervalued or overvalued right now?
TARS is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for TARS: open their intrinsic value pages.